The findings show that Wegovy is effective in the long term, over multiple years, provided patients stay on it.
Wegovy reduced the risk of stroke by 20% in overweight or obese people with a history of heart disease.
Researchers are conducting studies to understand how Wegovy's active ingredient, semaglutide, provides cardiovascular benefits beyond just weight loss.
[
add
]
[
|
|
...
]